FDA Proposes Mandatory GRAS Notifications, Signals Increased US Regulatory Scrutiny
The US FDA's proposal for mandatory GRAS notifications indicates a significant shift in ingredient regulation, coinciding with federal efforts to define ultra-processed foods. This move will increase compliance burdens and demand greater transparency from supplement manufacturers operating in or supplying to the US market.
AI-assisted coverage: produced by SF News' automated newsroom from the cited sources and checked by automated attribution gates. Editorial responsibility: Lee Smith, Group CEO. How we work →
Washington D.C., United States — 31 August 2026
The US Food and Drug Administration (FDA) has proposed a critical change to its Generally Recognized As Safe (GRAS) process, moving from a voluntary notification system to a mandatory one. This regulatory shift, reported by Food Ingredients First, requires companies to formally notify the FDA whenever they conclude an ingredient is GRAS. The proposal coincides with federal agencies actively working to establish a definition for 'ultra-processed foods,' signalling a broader governmental push for enhanced oversight of ingredient safety, formulation practices, and transparency across the entire US food and supplement industry.
Historically, the voluntary GRAS system has allowed companies to self-affirm an ingredient's safety without direct FDA approval, provided it met specific scientific standards. The proposed mandatory notification will impose a new layer of regulatory burden, demanding more rigorous documentation and potentially extending the timeline for novel ingredient commercialisation. This change directly impacts supplement manufacturers who utilise GRAS ingredients or introduce new ones, necessitating a re-evaluation of current ingredient approval processes and a robust investment in safety data substantiation.
The concurrent focus on 'ultra-processed foods' indicates that the FDA is not merely refining processes but is moving towards a more prescriptive regulatory environment. While the direct implications for supplements are still evolving, this trajectory suggests future scrutiny could extend to common supplement excipients, processing aids, and multi-ingredient formulations. Brand owners and manufacturers must anticipate potential reformulation windows and invest in clean label alternatives or clearer ingredient declarations to mitigate future compliance risks.
Further market insights from August 2026 reveal that the GLP-1 medication trend continues to reshape consumer demand, pushing nutrient density and metabolic health into the mainstream. Companies like Nestlé are reformulating for smaller, nutrient-dense portions, and Tate & Lyle identifies new 'white space' in metabolic health for fiber, protein, and sugar reduction. This trend could drive demand for specific functional ingredients in the supplement sector, such as high-quality proteins and fibres, but requires manufacturers to demonstrate clear efficacy and safety, particularly under a stricter GRAS regime.
What this means for United States
US supplement manufacturers must immediately audit all GRAS-affirmed ingredients, ensuring robust scientific dossiers are prepared for upcoming mandatory notifications. Expect increased compliance costs and potential 6-12 month delays for novel ingredient market entry as the FDA processes new submissions. Brand owners should proactively review product formulations for potential 'ultra-processed' classification risks, prioritising clean label reformulations to maintain competitive positioning. Ingredient suppliers face enhanced data requirements and must invest in comprehensive safety studies to support customer compliance, potentially leading to higher ingredient costs. Regulatory compliance teams need to monitor specific FDA guidance on 'ultra-processed foods' criteria, anticipated within the next 18 months, to pre-emptively adapt product portfolios.
The broader supply chain faces additional challenges. Rabobank warned of El Niño-induced commodity disruptions through 2027, impacting cocoa, palm oil, and sugar. These pressures will increase raw material costs and necessitate diversification of sourcing strategies for manufacturers reliant on these commodities, further compressing margins already under pressure from regulatory compliance costs. The emphasis on protein innovation, moving beyond mere gram counts to focus on quality and functionality across plant, dairy, and fermentation-derived sources, presents opportunities for brands to differentiate but also demands careful supplier vetting and supply chain resilience planning.
Many leading brands in this category are manufactured in partnership with Supplement Factory.